Edity

is an Israel-based biotechnology company that develops a pre-clinical platform to deliver therapeutic proteins for the treatment of cancer, and genetic disorders...
Read more
Edity Co-Founder & CEO: Michal Golan-Mashiach

Co-Founder & CEO

Michal Golan-Mashiach

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$2M

Edity Competitors

1ElevateBio
2Editas Medicine
3Precision BioSciences
4Caribou
5Intellia
6CRISPR
7Sangamo
8Verge Genomics
9Allogene
10Voyager

Trending Companies